UNSPSC 85921105: Medication management for substance abuse treatment, naloxone

This classification denotes the group of activities that yields a substance abuse treatment intervention or procedure of medication management for substance abuse treatment, naloxonemedication management for substance abuse treatment, naloxone. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code HZ85ZZZ

UNSPSC 85921105 Medication management for substance abuse treatment, naloxone is a Commodity code. State and local governments buying under this code procure naloxone formulations, delivery systems, and related resources to support overdose prevention programs and substance abuse treatment infrastructure. The recent opportunities block shows substantial mismatch between the code's nominal scope and the work actually being solicited. Of the twenty-five recent state and local opportunities posted, only one — the Florida Department of Children and Families' RFP for emergency opioid antagonist products and resources — aligns directly with the code name. The remaining twenty-four opportunities span speech-language pathology staffing, special education services, occupational and physical therapy, orientation and mobility services, victim advocacy, recovery housing, athletic training, and other clinical and social services entirely outside medication management or naloxone procurement. This pattern suggests the code assignment in the source data is systematically incorrect or the opportunities have been mistagged.

The single directly relevant opportunity is the State of Florida, Department of Children and Families (SAMH division) issuing RFP 2627 020 for emergency opioid antagonist products and resources to supply the Overdose Prevention Program, with responses due November 10, 2026 (after multiple addenda extending the deadline). The scope includes intranasal antagonist products in multiple milligram strengths, prefilled syringes, auto-injectors, and vials with educational materials in English, Spanish, and Haitian Creole; all products must be manufactured and assembled in the USA with minimum thirty-month shelf-life. The Department will award to one or more respondents per product, delivers to approximately 1,500 authorized Enrolled Distributors statewide with two-day shipping at no cost, and requires respondents to demonstrate shipping capability of at least 65,000 units monthly to distributors. The contract term is one year (start November 20, 2026) with potential renewal for up to three additional years. Financially, the Department scores lowest-cost respondent proposals at 40 points maximum, with programmatic components (executive overview, core team qualifications, service capability, project approach, prior projects) weighted at 30 points, for a 70-point total evaluation framework. The code shows little relevant recent activity beyond this single opportunity; the remaining opportunities in the dataset do not belong to UNSPSC 85921105 and should be recoded.